Sunho Biologics, Inc. (HKG:2898)

Sunho Biologics Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Other Revenue	0.02	0.04	17.53	1.85	3.22
Revenue	0.02	0.04	17.53	1.85	3.22
Revenue Growth (YoY)	-99.85%	-99.78%	847.78%	-42.48%	-
Gross Profit	0.02	0.04	17.53	1.85	3.22
Selling, General & Admin	27.68	30.28	40.7	5.56	5.8
Research & Development	62.18	71.12	43.04	53.17	64.03
Other Operating Expenses	-	-	0.07	1.26	-
Operating Expenses	89.86	101.39	83.81	59.99	69.83
Operating Income	-89.84	-101.36	-66.28	-58.14	-66.62
Interest Expense	-1.18	-0.92	-0.69	-5.07	-4.17
Interest & Investment Income	12.72	9.45	3.47	0.02	0.01
Currency Exchange Gain (Loss)	-0.04	3.84	-8.29	0.03	-0
Other Non Operating Income (Expenses)	-2.72	9.02	-60.91	11.18	0.01
EBT Excluding Unusual Items	-81.07	-79.97	-132.7	-51.99	-70.78
Gain (Loss) on Sale of Investments	-1.02	-	-	-	0.15
Pretax Income	-82.09	-79.97	-132.7	-51.99	-70.63
Net Income	-82.09	-79.97	-132.7	-51.99	-70.63
Net Income to Common	-82.09	-79.97	-132.7	-51.99	-70.63
Shares Outstanding (Basic)	151	128	93	91	91
Shares Outstanding (Diluted)	151	128	93	91	91
Shares Change (YoY)	51.27%	38.04%	2.07%	-	-
EPS (Basic)	-0.54	-0.62	-1.43	-0.57	-0.78
EPS (Diluted)	-0.54	-0.62	-1.43	-0.57	-0.78
Free Cash Flow	-65.98	-148.39	-41.68	-36.03	-58.17
Free Cash Flow Per Share	-0.44	-1.16	-0.45	-0.40	-0.64
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-528488.23%	-266723.68%	-378.00%	-3142.54%	-2071.39%
Profit Margin	-482864.71%	-210434.21%	-756.82%	-2810.16%	-2196.27%
Free Cash Flow Margin	-388135.29%	-390505.26%	-237.73%	-1947.30%	-1808.71%
EBITDA	-82.77	-94.41	-59.88	-51.54	-64.21
D&A For EBITDA	7.08	6.95	6.4	6.6	2.4
EBIT	-89.84	-101.36	-66.28	-58.14	-66.62

Source: S&P Global Market Intelligence. Standard template. Financial Sources.